author-photo

James Khatcheressian

Virginia Commonwealth University

32

Papers

3959

Citations

Citation Trend

Filter By

Papers (22) Sort By

Journal Conference Others

RAPID AND DURABLE RESPONSES WITH THE SYK/JAK INHIBITOR CERDULATINIB IN A PHASE 2 STUDY IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA—ALONE OR IN COMBINATION WITH RITUXIMAB

2019 Hematological Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Rapid and Durable Responses with the SYK/JAK Inhibitor Cerdulatinib in a Phase 2 Study in Relapsed/Refractory Follicular Lymphoma-Alone or in Combination with Rituximab

2019 Blood
Show All
- Source
- Cite
- Save
Citations (3)
The dual SYK/JAK inhibitor cerdulatinib demonstrates rapid tumor responses in a phase 2 study in patients with relapsed/refractory B- and T-cell non-Hodgkin lymphoma (NHL).

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)
THE DUAL SYK/JAK INHIBITOR CERDULATINIB DEMONSTRATES RAPID TUMOR RESPONSES IN a PHASE 2 STUDY IN PATIENTS WITH RELAPSED/REFRACTORY B‐CELL MALIGNANCIES

2017 Hematological Oncology
Show All
- Source
- Cite
- Save
Citations (4)
Randomized Phase II Study of Ramucirumab or Icrucumab in Combination with Capecitabine in Patients with Previously Treated Locally Advanced or Metastatic Breast Cancer

2017 Oncologist
Show All
- Source
- Cite
- Save
Citations (14)
Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update

2015 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (458)
CALGB 70604 (Alliance): A randomized phase III study of standard dosing vs. longer interval dosing of zoledronic acid in metastatic cancer.

2015 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (22)
A pilot trial of decision aids to give truthful prognostic and treatment information to chemotherapy patients with advanced cancer.

2011 The journal of supportive oncology
Show All
- Source
- Cite
- Save
Citations (81)
American Society of Clinical Oncology Endorsement of the Cancer Care Ontario Practice Guideline on Adjuvant Ovarian Ablation in the Treatment of Premenopausal Women With Early-Stage Invasive Breast Cancer

2011 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (50)
Pilot trial of decision aids for patients with advanced breast, lung, colorectal, or prostate cancer.

2010 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)